首页|期刊导航|Traditional Medicine Research|Xiao-Ke-Shen-An formula alleviates inflammation,oxidative stress and fibrosis in diabetic kidney disease via JAK2/STAT3 and metabolic regulation

Xiao-Ke-Shen-An formula alleviates inflammation,oxidative stress and fibrosis in diabetic kidney disease via JAK2/STAT3 and metabolic regulationOA

中文摘要

Background:The Xiao-Ke-Shen-An(XKSA)formula,as a traditional Chinese medicine for treating diabetic kidney disease(DKD),has demonstrated clinical benefits in alleviating diabetic complications and protecting renal function.However,the mechanism of action remains unclear.This study integrates network pharmacology,molecular docking,and metabolomics techniques to explore the potential mechanism of XKSA formula in treating DKD.Methods:UHPLC-MS/MS was used to identify the components of XKSA.Network pharmacology was applied to predict key signaling pathways,followed by metabolomics to identify differential metabolites.HE,PAS,and Masson staining were used to detect pathological damage of glomeruli and renal tubules;transmission electron microscopy was used to observe mitochondrial structure;ELISA,Western blotting,and immunofluorescence staining were used to verify the mechanism of XKSA in treating DKD.Results:26 main active components were identified by UHPLC-MS/MS analysis;network pharmacology analysis indicated that the JAK2/STAT3 pathway was a key regulatory pathway;metabolomics analysis showed that the XKSA formula significantly regulated 7 metabolites,including indoxyl sulfate(IS).In vivo experiments showed that the XKSA formula could significantly improve glycolipid metabolism disorders,enhance renal function,and alleviate renal pathological damage;in vivo and in vitro experiments found that XKSA reduced the expression of inflammatory factors,enhanced antioxidant capacity,improved mitochondrial structure,inhibited the expression of fibrotic proteins,and inhibited the activation of the JAK2/STAT3 pathway.In addition,IS stimulation could up-regulate KIM-1 protein expression,while XKSA down-regulated this expression in a dose-dependent manner and inhibited inflammation and oxidative stress,reversing the fibrotic trend.Conclusion:XKSA reduces the IS level and inhibits the JAK2/STAT3 signaling pathway,thereby alleviating the renal inflammation,oxidative stress and fibrosis caused by DKD.

He-Ying Cui;Peng-Bin Xu;Xiang-Dan Li;Shu-Hua Zheng;Chang-Qing Lin;Min-Hu Piao;Zheng Nan

Department of Traditional Chinese Medicine,Yanbian University School of Medicine,Yanji 133002,ChinaKey Laboratory of Cellular Function and Pharmacology of Jilin Province,Yanbian University School of Medicine,Yanji 133002,ChinaKey Laboratory of Cellular Function and Pharmacology of Jilin Province,Yanbian University School of Medicine,Yanji 133002,ChinaDepartment of Traditional Chinese Medicine,Yanbian University School of Medicine,Yanji 133002,ChinaDepartment of Traditional Chinese Medicine,Yanbian University School of Medicine,Yanji 133002,ChinaDepartment of Urology,Affiliated Hospital of Yanbian University,Yanji 133000,ChinaDepartment of Endocrinology,Affiliated Hospital of Changchun University of Traditional Chinese Medicine,Changchun 130000,China.

医药卫生

Xiao-Ke-Shen-An formuladiabetic kidney diseaseJAK2/STAT3 signaling pathwaymetabolomics analysis

《Traditional Medicine Research》 2027 (1)

P.27-41,15

supported by the National Natural Science Foundation of China(82360479)National Natural Science Foundation of Jilin Province(No.YDZJ202301ZYTS173).

10.53388/TMR2027003

评论